• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Science & Research

  • Print
  • Share
  • E-mail

Critical Path Initiative

Four images: Woman looking through microscope, Gloved hands holding test tube, Pills coming down a manufacturing shoot., Doctor holding a baby

Transforming the way FDA-regulated products are developed, evaluated, and manufactured


Highlights

 


About Critical Path


The Critical Path Initiative (CPI) is FDA's national strategy for transforming the way FDA-regulated medical products are developed, evaluated, and manufactured.  ... More

  

 

Contact FDA

FDA's Office of Critical Path and Regulatory Science Initiatives

Frank F. Weichold, MD, PhD

Acting Director

Critical Path and Regulatory Science Initiatives

301-796-8187

-